Results 121 to 130 of about 6,114 (196)

Serotonin receptor sensitivity after acute and chronic treatment with mianserin.

Journal of Pharmacology and Experimental Therapeutics, 1982
The chronic administration of mianserin for 14 days leads to a marked decrease in the maximal number of serotonin2 (5-HT2) binding sites in brains of rats and mice with no change in the KD values.
M. Blackshear, E. Sanders‐Bush
semanticscholar   +1 more source

Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.

Journal of Pharmacology and Experimental Therapeutics, 1996
The effects of three compounds with alpha-2 adrenoceptor antagonistic properties, mirtazapine (Org 3770; Remeron), mianserin and idazoxan, were measured on hippocampal noradrenergic and serotonergic transmission in freely moving rats by using ...
T. D. Boer, F. Nefkens, A. V. Helvoirt, A. V. Delft   +3 more
semanticscholar   +1 more source

Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.

Journal of Pharmacology and Experimental Therapeutics, 1996
To identify cytochrome P450 (CYP) isoform(s) involved in the major metabolic pathways of mianserin (MS) enantiomers in humans, we examined the metabolites formed from S-(+)- and R-(-)-MS using human liver microsomes and eight recombinant human CYP ...
E. Koyama, Kan Chiba, Masayoshi Tani, Takashi Ishizaki   +3 more
semanticscholar   +1 more source

Effects of Intra-VMN Mianserin and IL-1ra on Meal Number in Anorectic Tumor-Bearing Rats

Journal of Investigative Medicine, 2000
Background Tumor growth in animals and humans is associated with the onset of anorexia and reduced food intake. We previously demonstrated that the ventromedial nucleus of hypothalamus (VMN) plays a contributory role in mediating cancer anorexia. Because
Alessandro Laviano, John R. Gleason, Michael M. Meguid, Zhong-Jin Yang, C. Cangiano, F. Rossi Fanelli   +5 more
semanticscholar   +1 more source

Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophrenia

International Clinical Psychopharmacology, 2002
The beneficial effect of atypical antipsychotic drugs (APDs) in treatment-resistant schizophrenia patients has been attributed, mostly, to their relatively high serotonergic (5-HT)2 to dopaminergic (D)2 receptor blockade ratio.
R. Shiloh, Z. Zemishlany, D. Aizenberg, A. Valevski, L. Bodinger, H. Munitz, Abraham Weizman   +6 more
semanticscholar   +1 more source

Mianserin

Reactions Weekly, 2010
Michael M. Morgan, MacDonald J. Christie, Thomas Steckler, Ben J. Harrison, Christos Pantelis, Christof Baltes, Thomas Mueggler, Markus Rudin, Lawrence H. Price, Malcolm Lader, R. H. Belmaker, Joseph H. Friedman, Peter Verhaert, Per Svenningsson, Per E. Andrén, Giovanni Hernandez, Peter Shizgal, Bart Ellenbroek, Trevor W. Robbins, Peter Verhaert, Per Svenningsson, Per E. Andrén, Paul Newhouse, Heather Wilkins, Lance R. McMahon, Luis Stinus, Stéphanie Caillé, Martine Cador, Mary E. Cain, Michael T. Bardo, Sarah Morgan, Angus Mackay, Lucio Tremolizzo, Gessica Sala, Carlo Ferrarese, Alfonso Abizaid, Shimon Amir, Alfonso Abizaid, Shimon Amir, Stephen M. Stahl, Meghan M. Grady, Theodora Duka, Rodrigo Andrade, Yesne Alici, William Breitbart, Debby Van Dam, Peter Paul De Deyn, Warren H. Meck, Catalin V. Buhusi, Malcolm Lader, Martine Cador, Marie-Louise G. Wadenberg, Tomek J. Banasikowski, Richard J. Beninger, Stefan Leucht, Kim Wolff, Peter Verhaert, Per Svenningsson, Per E. Andrén, Elizabeth C. Warburton, Anne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, Johannes Mosbacher, Gabriele Fischer, Annemarie Unger, Martine Cador, Ian P. Stolerman, Seiya Miyamoto, Iain S. McGregor, Murray R. Thompson, Paul D. Callaghan, Trevor W. Robbins, Nachum Dafny, Bernard Le Foll, Theodora Duka, Albert Adell, Francesc Artigas, Anne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, Roberto William Invernizzi, Ennio Esposito, Jelena Nesic, Theodora Duka, Yesne Alici, William Breitbart, Josef Marksteiner, Irene Adelt, Huaiyu Yang, George I. Papakostas, Malcolm Lader, Klaus A. Miczek, R. Hamish McAllister-Williams, Tomasz Schneider, Stephen B. Dunnett, Andrew Young, Klaus A. Miczek, Michael Minzenberg, W. Wolfgang Fleischhacker, Andrew Holt, Darrell D. Mousseau, Glen B. Baker, Stephen M. Stahl, Meghan M. Grady, Andreas Marneros, Guy M. Goodwin, Seiya Miyamoto, Mohammed Shoaib, Mitul A. Mehta, Seiya Miyamoto, Stephen C. Fowler, Joachim Liepert, Thomas R. E. Barnes, Christof Baltes, Thomas Mueggler, Markus Rudin, Ennio Esposito, Roberto William Invernizzi, Josee E. Leysen, Ben J. Harrison, Christos Pantelis, Ronald F. Mucha, Holden D. Brown, Michael E. Ragozzino, Michael E. Ragozzino, Holden D. Brown, Paul Newhouse, Heather Wilkins, R. Andrew Chambers   +129 more
  +4 more sources

SAFETY OF MIANSERIN

The Lancet, 1988
D N, Bateman, S, Chaplin, R E, Ferner
openaire   +4 more sources

Mianserin

2015
R M, Pinder, M, Fink
openaire   +3 more sources

The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset

Progress in Neuro-psychopharmacology and Biological Psychiatry, 2018
Adjia Hamadjida, Stephen Nuara, Jim C. Gourdon, P. Huot   +3 more
semanticscholar   +1 more source

Mianserin

Reactions Weekly, 2023
openaire   +1 more source